Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Orthofix Medical Inc. (OFIX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Orthofix Medical Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 884624.
Total stock buying since 2015: $6,140,771.
Total stock sales since 2015: $22,697,724.
Total stock option exercises since 2015: $7,875,933.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 127,404 | $1,617,942 | 41,683 | $658,593 | 0 | $0 |
| 2024 | 0 | $0 | 26 | $463 | 5,959 | $0 |
| 2023 | 7,500 | $101,025 | 12,505 | $232,267 | 0 | $0 |
| 2021 | 7,730 | $236,961 | 0 | $0 | 0 | $0 |
| 2020 | 32,900 | $856,364 | 8,750 | $327,320 | 8,750 | $190,575 |
| 2019 | 20,000 | $845,560 | 60,712 | $3,475,245 | 32,372 | $0 |
| 2018 | 10,000 | $519,720 | 124,098 | $7,359,463 | 71,300 | $1,941,725 |
| 2017 | 0 | $0 | 38,753 | $1,940,676 | 28,967 | $1,302,645 |
| 2016 | 0 | $0 | 154,592 | $6,706,934 | 136,937 | $4,440,988 |
| 2015 | 60,000 | $1,963,199 | 49,867 | $1,996,763 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 1,996 | $28,363 | 0 | $0 |
| 2025-07 | 1,250 | $13,881 | 0 | $0 | 0 | $0 |
| 2025-06 | 2,250 | $24,570 | 5,371 | $58,305 | 0 | $0 |
| 2025-05 | 113,990 | $1,406,690 | 0 | $0 | 0 | $0 |
| 2025-04 | 0 | $0 | 3,892 | $51,986 | 0 | $0 |
| 2025-03 | 9,914 | $172,801 | 4,583 | $76,077 | 0 | $0 |
| 2025-02 | 0 | $0 | 954 | $17,024 | 0 | $0 |
| 2025-01 | 0 | $0 | 24,887 | $426,838 | 0 | $0 |
| 2024-12 | 0 | $0 | 26 | $463 | 0 | $0 |
| 2024-01 | 0 | $0 | 0 | $0 | 5,959 | $0 |
| 2023-09 | 7,500 | $101,025 | 0 | $0 | 0 | $0 |
| 2023-05 | 0 | $0 | 8,243 | $156,617 | 0 | $0 |
| 2023-03 | 0 | $0 | 4,262 | $75,650 | 0 | $0 |
| 2021-11 | 7,730 | $236,961 | 0 | $0 | 0 | $0 |
| 2020-06 | 0 | $0 | 8,750 | $327,320 | 8,750 | $190,575 |
| 2020-03 | 30,000 | $753,470 | 0 | $0 | 0 | $0 |
| 2020-02 | 2,900 | $102,894 | 0 | $0 | 0 | $0 |
| 2019-10 | 20,000 | $845,560 | 0 | $0 | 0 | $0 |
| 2019-08 | 0 | $0 | 5,805 | $295,875 | 0 | $0 |
| 2019-07 | 0 | $0 | 0 | $0 | 32,372 | $0 |
| 2019-06 | 0 | $0 | 8,890 | $454,999 | 0 | $0 |
| 2019-05 | 0 | $0 | 10,668 | $576,616 | 0 | $0 |
| 2019-04 | 0 | $0 | 5,949 | $311,091 | 0 | $0 |
| 2019-02 | 0 | $0 | 24,400 | $1,586,000 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | Fisher Patrick (President, Global Orthopedics) | Sale | 1,996 | 14.21 | 28,363 |
| 2025-07-02 | Ajdler Arnaud | Buy | 1,250 | 11.11 | 13,881 |
| 2025-06-18 | Mcpherron Aviva (Pres, Global Ops & Qual) | Sale | 3,728 | 10.51 | 39,181 |
| 2025-06-11 | Reinhardt Max (President, Global Spine) | Sale | 1,643 | 11.64 | 19,124 |
| 2025-06-04 | Bazaar Alan Lee | Buy | 2,250 | 10.92 | 24,570 |
| 2025-05-12 | Bazaar Alan Lee | Buy | 2,000 | 12.59 | 25,172 |
| 2025-05-09 | Calafiore Massimo (President & CEO) | Buy | 10,000 | 12.54 | 125,399 |
| 2025-05-09 | Bazaar Alan Lee | Buy | 1,990 | 12.62 | 25,119 |
| 2025-05-07 | Ajdler Arnaud | Buy | 100,000 | 12.31 | 1,231,000 |
| 2025-04-16 | Cedron Jorge Andres (CLO) | Sale | 3,816 | 13.31 | 50,790 |
| 2025-04-02 | Gillespie Geoffrey C (CAO) | Sale | 76 | 15.74 | 1,196 |
| 2025-03-18 | Gillespie Geoffrey C (CAO) | Sale | 296 | 16.60 | 4,913 |
| 2025-03-18 | Vitale Lucas (CP&BOO) | Sale | 4,287 | 16.60 | 71,164 |
| 2025-03-05 | Calafiore Massimo (President & CEO) | Buy | 9,914 | 17.43 | 172,801 |
| 2025-02-04 | Gillespie Geoffrey C (CAO) | Sale | 187 | 18.08 | 3,380 |
| 2025-02-03 | Gillespie Geoffrey C (CAO) | Sale | 767 | 17.79 | 13,644 |
| 2025-01-16 | Andrews Julie (CFO) | Sale | 4,655 | 17.89 | 83,277 |
| 2025-01-13 | Gillespie Geoffrey C (CAO) | Sale | 227 | 17.14 | 3,891 |
| 2025-01-13 | Calafiore Massimo (President & CEO) | Sale | 9,203 | 17.14 | 157,757 |
| 2025-01-10 | Gillespie Geoffrey C (CAO) | Sale | 248 | 16.83 | 4,174 |
| 2025-01-10 | Calafiore Massimo (President & CEO) | Sale | 10,078 | 16.83 | 169,622 |
| 2025-01-08 | Gillespie Geoffrey C (CAO) | Sale | 238 | 16.97 | 4,039 |
| 2025-01-07 | Gillespie Geoffrey C (CAO) | Sale | 238 | 17.14 | 4,078 |
| 2024-12-17 | Gillespie Geoffrey C (CAO) | Sale | 26 | 17.84 | 463 |
| 2024-01-08 | Kenny Kevin J. (President of Global Spine) | Option Ex | 5,959 | .00 | 0 |
| 2023-09-14 | Hinrichs James F. (Director) | Buy | 7,500 | 13.47 | 101,025 |
| 2023-05-26 | Kenny Kevin J. (President of Global Spine) | Sale | 3,876 | 19.00 | 73,644 |
| 2023-05-24 | Kenny Kevin J. (President of Global Spine) | Sale | 4,367 | 19.00 | 82,973 |
| 2023-03-10 | Maniar Shweta (Director) | Sale | 4,262 | 17.75 | 75,650 |
| 2021-11-22 | Paolucci Michael E (Director) | Buy | 2,000 | 31.15 | 62,300 |
| 2021-11-19 | Doug Rice (CFO) | Buy | 1,400 | 30.05 | 42,070 |
| 2021-11-19 | Burzik Catherine M (Director) | Buy | 1,660 | 30.27 | 50,248 |
| 2021-11-18 | Elting Kimberley A. (Chief Legal & Develop. Officer) | Buy | 1,000 | 30.34 | 30,340 |
| 2021-11-18 | Serbousek Jon Carl (CEO) | Buy | 1,670 | 31.14 | 52,003 |
| 2020-06-05 | Finegan Michael (Chief Strategy Officer) | Sale | 8,750 | 37.41 | 327,320 |
| 2020-06-05 | Finegan Michael (Chief Strategy Officer) | Option Ex | 8,750 | 21.78 | 190,575 |
| 2020-03-16 | Matricaria Ronald A (Director) | Buy | 20,000 | 24.25 | 485,000 |
| 2020-03-12 | Hinrichs James F. (Director) | Buy | 10,000 | 26.85 | 268,470 |
| 2020-02-27 | Serbousek Jon Carl (CEO) | Buy | 2,900 | 35.48 | 102,894 |
| 2019-10-31 | Matricaria Ronald A (Director) | Buy | 20,000 | 42.28 | 845,560 |
| 2019-08-28 | Mason Brad (CEO) | Sale | 5,805 | 50.97 | 295,875 |
| 2019-07-08 | Niemann Bradley V. (President of Global Spine) | Option Ex | 3,330 | .00 | 0 |
| 2019-07-08 | Doug Rice (CFO) | Option Ex | 3,937 | .00 | 0 |
| 2019-07-08 | Bianchi Davide (President, Global Extremities) | Option Ex | 3,330 | .00 | 0 |
| 2019-07-08 | Mason Brad (CEO) | Option Ex | 18,150 | .00 | 0 |
| 2019-07-08 | Finegan Michael (Chief Strategy Officer) | Option Ex | 3,625 | .00 | 0 |
| 2019-06-13 | Mason Brad (CEO) | Sale | 8,890 | 51.18 | 454,999 |
| 2019-05-14 | Mason Brad (CEO) | Sale | 10,668 | 54.05 | 576,616 |
| 2019-04-17 | Mason Brad (CEO) | Sale | 5,949 | 52.29 | 311,091 |
| 2019-02-19 | Bianchi Davide (President, Global Extremities) | Sale | 24,199 | 65.00 | 1,572,935 |
| 2019-02-15 | Bianchi Davide (President, Global Extremities) | Sale | 201 | 65.00 | 13,065 |
| 2019-01-15 | Mason Brad (CEO) | Sale | 3,200 | 50.00 | 160,000 |
| 2019-01-14 | Mason Brad (CEO) | Sale | 1,800 | 50.37 | 90,664 |
| 2018-11-05 | Niemann Bradley V. (President of Global Spine) | Sale | 387 | 61.63 | 23,850 |
| 2018-11-02 | Doug Rice (CFO) | Sale | 6,057 | 61.54 | 372,723 |
| 2018-11-02 | Elting Kimberley A. (Chief Legal & Admin Officer) | Sale | 7,000 | 61.05 | 427,336 |
| 2018-11-02 | Elting Kimberley A. (Chief Legal & Admin Officer) | Option Ex | 7,000 | 42.89 | 300,230 |
| 2018-11-02 | Faulstick Luke T (Director) | Sale | 8,450 | 61.33 | 518,221 |
| 2018-11-02 | Faulstick Luke T (Director) | Option Ex | 4,300 | 32.13 | 138,159 |
| 2018-10-11 | Doug Rice (CFO) | Sale | 3,949 | 55.65 | 219,753 |
| 2018-09-05 | Mason Brad (CEO) | Sale | 2,500 | 53.02 | 132,555 |
| 2018-08-07 | Mason Brad (CEO) | Sale | 2,500 | 53.38 | 133,452 |
| 2018-07-10 | Mason Brad (CEO) | Sale | 2,500 | 58.62 | 146,555 |
| 2018-07-03 | Niemann Bradley V. (President of Global Spine) | Sale | 11,250 | 57.15 | 642,881 |
| 2018-07-03 | Niemann Bradley V. (President of Global Spine) | Option Ex | 11,250 | 24.57 | 276,468 |
| 2018-06-20 | Fujikawa Raymond (President Spine Fixation) | Sale | 32,243 | 60.33 | 1,945,155 |
| 2018-06-20 | Fujikawa Raymond (President Spine Fixation) | Option Ex | 18,750 | 22.27 | 417,468 |
| 2018-06-19 | Bianchi Davide (President Extremity Fixation) | Sale | 14,762 | 60.00 | 885,720 |
| 2018-06-18 | Finegan Michael (Chief Strategy Officer) | Sale | 30,000 | 58.88 | 1,766,400 |
| 2018-06-18 | Finegan Michael (Chief Strategy Officer) | Option Ex | 30,000 | 26.98 | 809,400 |
| 2018-06-14 | Mason Brad (CEO) | Sale | 2,500 | 57.95 | 144,862 |
| 2018-05-03 | Matricaria Ronald A (Director) | Buy | 10,000 | 51.97 | 519,720 |
| 2017-12-11 | Niemann Bradley V. (President Biostim) | Sale | 5,547 | 52.08 | 288,860 |
| 2017-11-28 | Mason Brad (CEO) | Sale | 5,000 | 53.48 | 267,400 |
| 2017-11-06 | Faulstick Luke T (Director) | Sale | 4,800 | 51.22 | 245,846 |
| 2017-09-11 | Niemann Bradley V. (President Biostim) | Sale | 6,956 | 49.44 | 343,925 |
| 2017-09-11 | Doug Rice (CFO) | Sale | 7,353 | 49.46 | 363,686 |
| 2017-08-21 | Mason Brad (CEO) | Sale | 2,733 | 48.10 | 131,457 |
| 2017-08-10 | Fujikawa Raymond (President Spine Fixation) | Sale | 6,364 | 47.06 | 299,502 |
| 2017-06-26 | Mason Brad (CEO) | Option Ex | 6,667 | 44.97 | 299,814 |
| 2017-06-26 | Finegan Michael (Chief Strategy Officer) | Option Ex | 22,300 | 44.97 | 1,002,831 |
| 2016-11-10 | Mason Brad (CEO) | Sale | 4,538 | 36.84 | 167,193 |
| 2016-11-08 | Mason Brad (CEO) | Sale | 5,000 | 36.81 | 184,075 |
| 2016-09-01 | Finegan Michael (Chief Strategy Officer) | Sale | 25,000 | 45.16 | 1,129,000 |
| 2016-09-01 | Finegan Michael (Chief Strategy Officer) | Option Ex | 25,000 | 23.63 | 590,675 |
| 2016-06-10 | Sainz Maria (Director) | Sale | 4,157 | 46.33 | 192,589 |
| 2016-06-09 | Mason Brad (CEO) | Sale | 18,336 | 46.00 | 843,456 |
| 2016-06-09 | Mason Brad (CEO) | Option Ex | 20,000 | 38.11 | 762,200 |
| 2016-06-08 | Niemann Bradley V. (President Biostim) | Sale | 3,402 | 44.70 | 152,069 |
| 2016-05-20 | Goodwin Robert Allen Ii (President Biologics) | Sale | 13,187 | 44.00 | 580,228 |
| 2016-05-20 | Goodwin Robert Allen Ii (President Biologics) | Option Ex | 13,187 | 38.67 | 510,007 |
| 2016-04-18 | Finegan Michael (Chief Strategy Officer) | Sale | 28,750 | 44.00 | 1,265,000 |
| 2016-04-18 | Finegan Michael (Chief Strategy Officer) | Option Ex | 28,750 | 23.39 | 672,606 |
| 2016-04-14 | Finegan Michael (Chief Strategy Officer) | Sale | 52,222 | 42.00 | 2,193,324 |
| 2016-04-14 | Finegan Michael (Chief Strategy Officer) | Option Ex | 50,000 | 38.11 | 1,905,500 |
| 2015-11-11 | Finegan Michael (Chief Strategy Officer) | Sale | 14,140 | 42.00 | 593,880 |
| 2015-11-06 | Mason Brad (CEO) | Sale | 15,018 | 40.63 | 610,151 |
| 2015-11-06 | Schumm Jeffrey (Chief Administrative Officer) | Sale | 15,000 | 40.52 | 607,875 |
| 2015-06-02 | Matricaria Ronald A (Director) | Buy | 20,000 | 32.65 | 653,060 |
| 2015-06-01 | Matricaria Ronald A (Director) | Buy | 30,000 | 32.62 | 978,450 |
| 2015-05-21 | Hinrichs James F. (Director) | Buy | 10,000 | 33.17 | 331,689 |
| 2015-05-21 | Scoon Davey (Director) | Sale | 5,709 | 32.38 | 184,857 |
Insider trading activities including stock purchases, stock sales, and option exercises of OFIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Orthofix Medical Inc. (symbol OFIX, CIK number 884624) see the Securities and Exchange Commission (SEC) website.